SCHEMBL30888596

SCHEMBL30888596

Fc1cc2c(c(Br)c1Cl)OCCCC2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.32
PDE4A P27815 1/20 0.31
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24373459 0.78 NOTUM (0.37) NOTUM
SCHEMBL30774107 0.78 NOTUM (0.37) NOTUM
SCHEMBL30888655 0.76 PARP1 (0.36) NOTUMPDE4APARP1
SCHEMBL25166055 0.75 NOTUM (0.35) NOTUM
SCHEMBL4920199 0.75 PARP1 (0.33) NOTUMPARP1
SCHEMBL30888529 0.74
SCHEMBL22989890 0.70 SOS1 (0.31)
SCHEMBL30330341 0.70 GPR35 (0.35) NOTUM
SCHEMBL25166676 0.69 HTR2A (0.32)
SCHEMBL30748852 0.69 PARP1 (0.33) NOTUMPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630403-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121129-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed